Phased array radar

Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection

Retrieved on: 
Thursday, April 29, 2021

The MPAR\xe2\x84\xa2 overdose protection technology has been demonstrated in animals and the Phase 1 study with PF614 is being conducted to further validate the MPAR\xe2\x84\xa2 overdose protection technology.

Key Points: 
  • The MPAR\xe2\x84\xa2 overdose protection technology has been demonstrated in animals and the Phase 1 study with PF614 is being conducted to further validate the MPAR\xe2\x84\xa2 overdose protection technology.
  • \xe2\x80\x9cImportantly, our proprietary prodrug approach is highly differentiated from currently marketed opioid products and designed to significantly reduce abuse potential and overdose protection.
  • The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug prodrug compositions.
  • Additional information can be found at www.leisureacq.com .\nThis press release relates to a proposed transaction between Ensysce and LACQ.

Mikros Systems Announces Additional Navy Funding for Support of the ADEPT® Program

Retrieved on: 
Tuesday, October 1, 2019

Mikros Systems has received $2.75 million in U.S. Navy funding to support engineering and technical support of the ADEPTproduct line over the last twelve months.

Key Points: 
  • Mikros Systems has received $2.75 million in U.S. Navy funding to support engineering and technical support of the ADEPTproduct line over the last twelve months.
  • ADEPT is deployed on U.S. Navy guided-missile cruisers and destroyers to assist sailors in maintaining and optimizing the performance of critical systems, including advanced radars such as the AN/SPY-1 phased array radar used by the Aegis combat system.
  • Mikros Systems supports the 226 ADEPT systems currently deployed throughout the world from its Fort Washington, Pennsylvania and Largo, Florida facilities.
  • Mikros Systems Corporation is an advanced technology company specializing in the development and production of electronic systems technology for advanced maintenance in military, industrial and commercial applications.

Mikros Systems Announces Additional Navy Funding for Support of the ADEPT® Program

Retrieved on: 
Monday, July 1, 2019

Mikros Systems has received over $2.5 million in U.S. Navy funding to support engineering and technical support of the ADEPTproduct line over the last twelve months.

Key Points: 
  • Mikros Systems has received over $2.5 million in U.S. Navy funding to support engineering and technical support of the ADEPTproduct line over the last twelve months.
  • ADEPT is deployed on U.S. Navy guided-missile cruisers and destroyers to assist sailors in maintaining and optimizing the performance of critical systems, including advanced radars such as the AN/SPY-1 phased array radar used by the Aegis combat system.
  • Mikros Systems supports the 226 ADEPT systems currently deployed throughout the world from its Fort Washington, Pennsylvania and Largo, Florida facilities.
  • Mikros Systems Corporation is an advanced technology company specializing in the development and production of electronic systems technology for advanced maintenance in military, industrial and commercial applications.

Successful Aegis Combat System Test Brings BMD to Japanese Fleet

Retrieved on: 
Thursday, September 13, 2018

The Japanese Flight Test Mission-05 exercise on Sept. 11 successfully demonstrated organic engagement of a simple separating target.

Key Points: 
  • The Japanese Flight Test Mission-05 exercise on Sept. 11 successfully demonstrated organic engagement of a simple separating target.
  • The JS ATAGO is now the most advanced warship in the Japanese fleet following this modernization effort.
  • The JS ATAGO Aegis Weapon System merges BMD into an Integrated Air and Missile Defense capability using commercial-off-the-shelf and open architecture technologies including the Aegis Common Source Library (CSL).
  • This successful BMD test builds upon joint research investments by the United States and Japan.